Unknown

Dataset Information

0

An intrinsically labile ?-helix abutting the BCL9-binding site of ?-catenin is required for its inhibition by carnosic acid.


ABSTRACT: Wnt/?-catenin signalling controls development and tissue homeostasis. Moreover, activated ?-catenin can be oncogenic and, notably, drives colorectal cancer. Inhibiting oncogenic ?-catenin has proven a formidable challenge. Here we design a screen for small-molecule inhibitors of ?-catenin's binding to its cofactor BCL9, and discover five related natural compounds, including carnosic acid from rosemary, which attenuates transcriptional ?-catenin outputs in colorectal cancer cells. Evidence from NMR and analytical ultracentrifugation demonstrates that the carnosic acid response requires an intrinsically labile ?-helix (H1) amino-terminally abutting the BCL9-binding site in ?-catenin. Similarly, in colorectal cancer cells with hyperactive ?-catenin signalling, carnosic acid targets predominantly the transcriptionally active ('oncogenic') form of ?-catenin for proteasomal degradation in an H1-dependent manner. Hence, H1 is an 'Achilles' Heel' of ?-catenin, which can be exploited for destabilization of oncogenic ?-catenin by small molecules, providing proof-of-principle for a new strategy for developing direct inhibitors of oncogenic ?-catenin.

SUBMITTER: de la Roche M 

PROVIDER: S-EPMC3293410 | biostudies-literature | 2012 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid.

de la Roche Marc M   Rutherford Trevor J TJ   Gupta Deepti D   Veprintsev Dmitry B DB   Saxty Barbara B   Freund Stefan M SM   Bienz Mariann M  

Nature communications 20120221


Wnt/β-catenin signalling controls development and tissue homeostasis. Moreover, activated β-catenin can be oncogenic and, notably, drives colorectal cancer. Inhibiting oncogenic β-catenin has proven a formidable challenge. Here we design a screen for small-molecule inhibitors of β-catenin's binding to its cofactor BCL9, and discover five related natural compounds, including carnosic acid from rosemary, which attenuates transcriptional β-catenin outputs in colorectal cancer cells. Evidence from N  ...[more]

Similar Datasets

| S-EPMC10594212 | biostudies-literature
| S-EPMC7649839 | biostudies-literature
| S-EPMC3631420 | biostudies-literature
| S-EPMC3897473 | biostudies-literature
| S-EPMC6506245 | biostudies-literature
| S-EPMC3286869 | biostudies-literature
| S-EPMC4703711 | biostudies-literature
| S-EPMC3543496 | biostudies-literature
| S-EPMC3892132 | biostudies-literature
| S-EPMC5245867 | biostudies-literature